
KPLKwality Pharmaceuticals Ltd.
Kwality Pharmaceuticals Q2 FY27 Results: Consolidated Net Profit ₹29.03 Crore on Total Income of ₹182 Crore
Kwality Pharmaceuticals (NSE: KPL) reported consolidated total income of ₹181.99 crore and net profit of ₹29.03 crore for the quarter ended 30 Sep 2026. On a standalone basis, total income was ₹181.94 crore and net profit ₹29.02 crore. The company said so in a filing on 12 Nov 2026.
- Earnings
- Pharmaceuticals
